Incidence and Kinetics Of Full Donor Chimerism and The Impact Of Minimal Residual Disease Status Follo Outpatient Non-Myeloablative Allogeneic Stem Cell Transplantation For Myeloma

被引：0
|
作者：
Campbell, Philip
Das, Tongted
Kipp, David
Walker, Patricia A.
Muirhead, Jenny
Avery, Sharon
Patil, Sushrut S.
Curtis, David J.
Schwarer, Anthony P.
Kalff, Anna
Spencer, Andrew
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2129.2129
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2129
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Rapid immune reconstitution and complete donor chimerism after non-myeloablative allogeneic peripheral blood stem cell transplantation (NMSCT) in pediatric patients (PTS) with malignancy
    Fry, TJ
    Rager, A
    Hakim, F
    Love, C
    Layton, P
    Fowler, D
    Bishop, MR
    Gress, R
    Mackall, CL
    Wayne, AS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 80 - 81
  • [42] A Pilot Feasibility Study of non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Refractory Crohn Disease
    Burt, Richard
    Quigley, Kathleen
    Arnautovic, Indira
    Han, Xiaoqiang
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 228 - 228
  • [43] Incidence and outcome of thrombotic microangiopathy after allogeneic peripheral blood stem cell transplantation with non-myeloablative conditioning compared with myeloablative conditioning
    Willems, E
    Baron, F
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2006, 37 : S46 - S46
  • [44] Comparative analysis of chimerism in the early post-transplantation period in cellular subsets of patients undergoing myeloablative and non-myeloablative allogeneic blood stem cell transplantation (BSCT).
    Thiede, C
    Brendel, C
    Mohr, B
    Florek, M
    Oelschlägel, U
    Ritter, M
    Naumann, R
    Geissler, G
    Ehninger, G
    Neubauer, A
    Bornhäuser, M
    BLOOD, 1998, 92 (10) : 132A - 133A
  • [45] Impact of Minimal Residual Disease and Chimerism Monitoring at Different Timepoints after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
    Martin-Rojas, Reyes Maria
    Oarbeascoa, Gillen
    Bailen, Rebeca
    Gomez-Centurion, Ignacio
    Juarez, Luis Miguel
    Dorado, Nieves
    Martinez-Laperche, Carolina
    Perez-Corral, Ana
    Buno, Ismael
    Anguita, Javier
    Diez-Martin, Jose L.
    Kwon, Mi
    BLOOD, 2020, 136
  • [46] Infectious complications in non-myeloablative conditioning and allogeneic peripheral blood stem cell transplantation for patients with multiple myeloma.
    Lee, CK
    Dignani, C
    Barlogie, B
    Guido, T
    Morris, CL
    Badros, AZ
    Cottler-Fox, MH
    van Rhee, F
    Zanagari, M
    Fassas, A
    Anaissie, EJ
    BLOOD, 2002, 100 (11) : 627A - 627A
  • [47] A combination of tacrolimus and mycofenolat mofetil after non-myeloablative unrelated matched donor allogeneic blood stem cell transplantation
    Zohren, F.
    Fenk, R.
    Graef, T.
    Czibere, A.
    Pape, H.
    Safaian, N.
    Kondakci, M.
    Germing, U.
    Haas, R.
    Kobbe, G.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S90 - S90
  • [48] Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation
    F Garban
    M Attal
    JF Rossi
    C Payen
    N Fegueux
    JJ Sotto
    Leukemia, 2001, 15 : 642 - 646
  • [49] Impact of outpatient non-myeloablative haematopoietic stem cell transplantation in quality of life vs. conventional therapy
    Graciela Cantu-Rodriguez, Olga
    Sanchez-Cardenas, Monica
    Ruben Trevino-Montemayor, Oscar
    Homero Gutierrez-Aguirre, Cesar
    Tarin-Arzaga, Luz
    Carlos Jaime-Perez, Jose
    Gomez-Almaguer, David
    PSYCHOLOGY HEALTH & MEDICINE, 2016, 21 (01) : 10 - 19
  • [50] Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation
    Garban, F
    Attal, M
    Rossi, JF
    Payen, C
    Fegueux, N
    Sotto, JJ
    LEUKEMIA, 2001, 15 (04) : 642 - 646
12345